Levodopa-induced dyskinesia in Parkinson's disease drug pipeline
- Subtype of Parkinson's disease
Involuntary movements from chronic levodopa therapy in Parkinson's disease; a distinct treatment target from the underlying disease.
Compounds in development
No compounds populated for this indication yet.